Sana Biotechnology (SANA) Change in Account Payables (2020 - 2026)
Sana Biotechnology recorded quarterly Change in Account Payables of $454000.0 in Q1 2026, up 340.21% quarter-over-quarter from -$189000.0 in Q4 2025, and up 110.75% year-over-year from $215423.1 in Q1 2025.
Sana Biotechnology's Change in Account Payables history runs 7 years deep, the most recent figure standing at $454000.0 for Q1 2026.
- In Q1 2026, Change in Account Payables rose 110.75% year-over-year to $454000.0; the TTM figure through Mar 2026 stood at $1.1 million (up 163.54% YoY), while the FY2025 annual figure was -$3.5 million, down 357.44% from the prior year.
- Change in Account Payables came in at $454000.0 for Q1 2026 at Sana Biotechnology, up from -$189000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.3 million in Q4 2024 to a low of -$4.2 million in Q1 2025.
- A 5-year average of $21823.5 and a median of -$189000.0 in 2025 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables surged 270.73% in 2024 and plunged 296.99% in 2025, its largest moves.
- Sana Biotechnology's Change in Account Payables stood at -$1.1 million in 2022, then declined by 23.02% to -$1.3 million in 2023, then soared by 270.73% to $2.3 million in 2024, then tumbled by 108.29% to -$189000.0 in 2025, then surged by 340.21% to $454000.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $454000.0, -$189000.0, and -$357000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Sana Biotechnology | 890.09 Mn | 890.09 Mn | - | 454,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 454,000.00 |
| Mar 31, 2026 | 454,000.00 |
| Dec 31, 2025 | -189,000.00 |
| Dec 31, 2025 | -189,000.00 |
| Sep 30, 2025 | -357,000.00 |
| Sep 30, 2025 | -357,000.00 |
| Jun 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | -4.22 Mn |
| Mar 31, 2025 | -4.22 Mn |
| Dec 31, 2024 | 2.28 Mn |
| Dec 31, 2024 | 2.28 Mn |
| Sep 30, 2024 | -507,000.00 |
| Sep 30, 2024 | -507,000.00 |
| Jun 30, 2024 | 667,000.00 |
| Jun 30, 2024 | 667,000.00 |
| Mar 31, 2024 | -1.06 Mn |
| Mar 31, 2024 | -1.06 Mn |
| Dec 31, 2023 | -1.34 Mn |
| Dec 31, 2023 | -1.34 Mn |
| Sep 30, 2023 | 2.28 Mn |
| Sep 30, 2023 | 2.28 Mn |
| Jun 30, 2023 | 441,000.00 |
| Jun 30, 2023 | 441,000.00 |
| Mar 31, 2023 | -354,000.00 |
| Mar 31, 2023 | -354,000.00 |
| Dec 31, 2022 | -1.09 Mn |
| Dec 31, 2022 | -1.09 Mn |
| Sep 30, 2022 | 1.48 Mn |
| Sep 30, 2022 | 1.48 Mn |
| Jun 30, 2022 | -1.25 Mn |
| Jun 30, 2022 | -1.25 Mn |
| Mar 31, 2022 | 1.92 Mn |
| Mar 31, 2022 | 1.92 Mn |
| Dec 31, 2021 | -1.66 Mn |
| Dec 31, 2021 | -1.66 Mn |
| Sep 30, 2021 | 1.77 Mn |
| Sep 30, 2021 | 1.77 Mn |
| Jun 30, 2021 | -1.97 Mn |
| Jun 30, 2021 | -1.97 Mn |
| Mar 31, 2021 | 1.60 Mn |
| Mar 31, 2021 | 1.60 Mn |
| Dec 31, 2020 | -432,000.00 |
| Dec 31, 2020 | -432,000.00 |
| Sep 30, 2020 | 550,000.00 |
| Sep 30, 2020 | 550,000.00 |
| Jun 30, 2020 | -506,000.00 |
| Jun 30, 2020 | -506,000.00 |
| Mar 31, 2020 | 2.37 Mn |
| Mar 31, 2020 | 2.37 Mn |